Non-squamous EGFR Wt NSCLC
1 clinical trials · Condition
◉ Watch Non-squamous EGFR Wt NSCLC
| Record | Firm | Date |
|---|---|---|
| Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors (NCT07444814) | Whitehawk Therapeutics, Inc. | 2025-12-19 |
Track Non-squamous EGFR Wt NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.